Recent health news highlights key regulatory approvals and legal actions. The EU backs Novo Nordisk's Wegovy for an ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

Yet today, independent pharmacies like ours face a dire and immediate threat from pharmacy benefit managers (PBMs), whose unchecked practices are jeopardizing patient care and driving community ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...

In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...

In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

(AP) — The federal government is suing some big pharmacy benefit managers, or PBMs, over a system of drug rebates that ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The U.S. Federal Trade Commission is taking legal action against three of the country's largest pharmacy benefit managers, or PBMs.

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.

The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of insulin by using their position as middlemen in the U.S. drug ...